Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Establishes U.S. lab presence and expands testing services.
June 18, 2021
By: Kristin Brooks
Managing Editor, Contract Pharma
Solvias, an analytical testing, contract research, development and manufacturing company, has acquired Chemic Laboratories, Inc. based in Canton, MA. The acquisition provides Solvias with a strong presence in the U.S. and highly complementary lab testing capabilities. Financial terms were not disclosed. Chemic expands Solvias’ global presence and portfolio of integrated testing and analytical services. Chemic is Solvias’ first acquisition since partnering with health care investors Water Street Healthcare Partners and JLL Partners in June 2020 to strategically grow the company. Solvias has since recruited industry leaders to join its board and began a program to significantly upgrade and expand its information technology platform and infrastructure to support further global expansion plans. The company is pursuing organic investments and acquisitions to add specialized capabilities to support clients in the growing areas of biologics and cell & gene therapies. Joseph St. Laurent, co-founder, president and chief scientific officer, Chemic, said, “In the 20+ years we have grown Chemic, Solvias is the only organization we have encountered that shares our vision and has the team to build a world-renowned organization. Solvias is highly regarded for its scientific expertise, innovation and outstanding customer service. Together, we share a deep-seated commitment to our clients and complementary scientific knowledge and analytical services on a global scale.” Scott A. Goodrich, co-founder and site head, Chemic, added, “This is a great opportunity to further expand our offering in the Boston area, United States and beyond.” Karen Huebscher, Ph.D., chief executive officer, Solvias, said, “We are making great progress toward our goal of building Solvias into a global leader at the forefront of our industry. In a short amount of time, we have grown our teams, advanced organic initiatives and completed a strategic acquisition. Our combination with Chemic provides us with an important presence in the United States and extends our scientific capabilities to meaningfully benefit our customers and our mission of helping them bring safer and better products to market faster.” Chemic’s co-founders, St. Laurent and Goodrich, will join Solvias’ leadership team and continue to lead operations in the U.S. They also will continue to operate Chemic’s product development businesses as separate entities.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !